|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Conti CM, Maccauro G and Fulcheri M:
Psychological stress and cancer. Int J Immunopathol Pharmacol.
24:1–5. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clarke DM and Currie KC: Depression,
anxiety and their relationship with chronic diseases: A review of
the epidemiology, risk and treatment evidence. Med J Aust.
190:S54–S60. 2009.PubMed/NCBI
|
|
5
|
Lara HE, Dorfman M, Venegas M, Luza SM,
Luna SL, Mayerhofer A, Guimaraes MA, Rosa E, Silva AA and Ramírez
VD: Changes in sympathetic nerve activity of the mammalian ovary
during a normal estrous cycle and in polycystic ovary syndrome:
Studies on norepinephrine release. Microsc Res Tech. 59:495–502.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Quốc Lu'o'ng KV and Nguyễn LT: The roles
of beta-adrenergic receptors in tumorigenesis and the possible use
of beta-adrenergic blockers for cancer treatment: Possible genetic
and cell-signaling mechanisms. Cancer Manag Res. 4:431–445.
2012.PubMed/NCBI
|
|
7
|
Chan C, Lin HJ and Lin J:
Stress-associated hormone, norepinephrine, increases proliferation
and IL-6 levels of human pancreatic duct epithelial cells and can
be inhibited by the dietary agent, sulforaphane. Int J Oncol.
33:415–419. 2008.PubMed/NCBI
|
|
8
|
Guo K, Ma Q, Li J, Wang Z, Shan T, Li W,
Xu Q and Xie K: Interaction of the sympathetic nerve with
pancreatic cancer cells promotes perineural invasion through the
activation of STAT3 signaling. Mol Cancer Ther. 12:264–273. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang XY, Wang HC, Yuan Z, Huang J and
Zheng Q: Norepinephrine stimulates pancreatic cancer cell
proliferation, migration and invasion via β-adrenergic
receptor-dependent activation of P38/MAPK pathway.
Hepatogastroenterology. 59:889–893. 2012.PubMed/NCBI
|
|
10
|
Gordon WR, Arnett KL and Blacklow SC: The
molecular logic of Notch signaling-a structural and biochemical
perspective. J Cell Sci. 121:3109–3119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao J, Long B and Wang Z: Role of Notch
signaling pathway in pancreatic cancer. Am J Cancer Res. 7:173–186.
2017.PubMed/NCBI
|
|
12
|
Vinson KE, George DC, Fender AW, Bertrand
FE and Sigounas G: The Notch pathway in colorectal cancer. Int J
Cancer. 138:1835–1842. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
O'Brien R and Marignol L: The Notch-1
receptor in prostate tumorigenesis. Cancer Treat Rev. 56:36–46.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brzozowa-Zasada M, Piecuch A, Dittfeld A,
Mielańczyk Ł, Michalski M, Wyrobiec G, Harabin-Słowińska M, Kurek J
and Wojnicz R: Notch signalling pathway as an oncogenic factor
involved in cancer development. Contemp Oncol. 20:267–272.
2016.
|
|
15
|
Liu J, Shen JX, Wen XF, Guo YX and Zhang
GJ: Targeting Notch degradation system provides promise for breast
cancer therapeutics. Crit Rev Oncol Hematol. 104:21–29. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jensen J: Gene regulatory factors in
pancreatic development. Dev Dyn. 229:176–200. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Siveke JT, Lubeseder-Martellato C, Lee M,
Mazur PK, Nakhai H, Radtke F and Schmid RM: Notch signaling is
required for exocrine regeneration after acute pancreatitis.
Gastroenterology. 134:544–555. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miyamoto Y, Maitra A, Ghosh B, Zechner U,
Argani P, Iacobuzio-Donahue CA, Sriuranpong V, Iso T, Meszoely IM,
Wolfe MS, et al: Notch mediates TGF alpha-induced changes in
epithelial differentiation during pancreatic tumorigenesis. Cancer
Cell. 3:565–576. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De La O JP, Emerson LL, Goodman JL, Froebe
SC, Illum BE, Curtis AB and Murtaugh LC: Notch and Kras reprogram
pancreatic acinar cells to ductal intraepithelial neoplasia. Proc
Natl Acad Sci USA. 105:18907–18912. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duncan AW, Rattis FM, DiMascio LN, Congdon
KL, Pazianos G, Zhao C, Yoon K, Cook JM, Willert K, Gaiano N, et
al: Integration of Notch and Wnt signaling in hematopoietic stem
cell maintenance. Nat Immunol. 6:314–322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Spiegel A, Kalinkovich A, Shivtiel S,
Kollet O and Lapidot T: Stem cell regulation via dynamic
interactions of the nervous and immune systems with the
microenvironment. Cell Stem Cell. 3:484–492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen H, Liu D, Yang Z, Sun L, Deng Q, Yang
S, Qian L, Guo L, Yu M, Hu M, et al: Adrenergic signaling promotes
angiogenesis through endothelial cell-tumor cell crosstalk. Endocr
Relat Cancer. 21:783–795. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duan W, Chen K, Jiang Z, Chen X, Sun L, Li
J, Lei J, Xu Q, Ma J, Li X, et al: Desmoplasia suppression by
metformin-mediated AMPK activation inhibits pancreatic cancer
progression. Cancer Lett. 385:225–233. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Ma G, Ma Q, Li W, Liu J, Han L, Duan
W, Xu Q, Liu H, Wang Z, et al: Neurotransmitter substance P
mediates pancreatic cancer perineural invasion via NK-1R in cancer
cells. Mol Cancer Res. 11:294–302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu J, Ma J, Wu Z, Li W, Zhang D, Han L,
Wang F, Reindl KM, Wu E and Ma Q: Arginine deiminase augments the
chemosensitivity of argininosuccinate synthetase-deficient
pancreatic cancer cells to gemcitabine via inhibition of NF-κB
signaling. BMC Cancer. 14:6862014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang D, Lei J, Ma J, Chen X, Sheng L,
Jiang Z, Nan L, Xu Q, Duan W, Wang Z, et al: β2-adrenogenic
signaling regulates NNK-induced pancreatic cancer progression via
upregulation of HIF-1α. Oncotarget. 7:17760–17772. 2016.PubMed/NCBI
|
|
28
|
Weddle DL, Tithoff P, Williams M and
Schuller HM: Beta-adrenergic growth regulation of human cancer cell
lines derived from pancreatic ductal carcinomas. Carcinogenesis.
22:473–479. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vere CC, Streba CT, Streba LM, Ionescu AG
and Sima F: Psychosocial stress and liver disease status. World J
Gastroenterol. 15:2980–2986. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schuller HM, Al-Wadei HA, Ullah MF and
Plummer HK III: Regulation of pancreatic cancer by
neuropsychological stress responses: A novel target for
intervention. Carcinogenesis. 33:191–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Herman JP, Figueiredo H, Mueller NK,
Ulrich-Lai Y, Ostrander MM, Choi DC and Cullinan WE: Central
mechanisms of stress integration: Hierarchical circuitry
controlling hypothalamo-pituitary-adrenocortical responsiveness.
Front Neuroendocrinol. 24:151–180. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schmidt C and Kraft K: Beta-endorphin and
catecholamine concentrations during chronic and acute stress in
intensive care patients. Eur J Med Res. 1:528–532. 1996.PubMed/NCBI
|
|
33
|
Zabora J, BrintzenhofeSzoc K, Curbow B,
Hooker C and Piantadosi S: The prevalence of psychological distress
by cancer site. Psychooncology. 10:19–28. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schuller HM, Al-Wadei HA and Majidi M:
GABA B receptor is a novel drug target for pancreatic cancer.
Cancer. 112:767–778. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Friedman GD, Udaltsova N and Habel LA:
Norepinephrine antagonists and cancer risk. Int J Cancer.
128:737–738. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dotto GP: Notch tumor suppressor function.
Oncogene. 27:5115–5123. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nakhai H, Siveke JT, Klein B,
Mendoza-Torres L, Mazur PK, Algül H, Radtke F, Strobl L,
Zimber-Strobl U and Schmid RM: Conditional ablation of Notch
signaling in pancreatic development. Development. 135:2757–2765.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mazur PK, Einwächter H, Lee M, Sipos B,
Nakhai H, Rad R, Zimber-Strobl U, Strobl LJ, Radtke F, Klöppel G,
et al: Notch2 is required for progression of pancreatic
intraepithelial neoplasia and development of pancreatic ductal
adenocarcinoma. Proc Natl Acad Sci USA. 107:13438–13443. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hanlon L, Avila JL, Demarest RM, Troutman
S, Allen M, Ratti F, Rustgi AK, Stanger BZ, Radtke F, Adsay V, et
al: Notch1 functions as a tumor suppressor in a model of
K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res.
70:4280–4286. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Feldmann G, Mishra A, Bisht S, Karikari C,
Garrido-Laguna I, Rasheed Z, Ottenhof NA, Dadon T, Alvarez H,
Fendrich V, et al: Cyclin-dependent kinase inhibitor Dinaciclib
(SCH727965) inhibits pancreatic cancer growth and progression in
murine xenograft models. Cancer Biol Ther. 12:598–609. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Z, Zhang Y, Banerjee S, Li Y and
Sarkar FH: Notch-1 down-regulation by curcumin is associated with
the inhibition of cell growth and the induction of apoptosis in
pancreatic cancer cells. Cancer. 106:2503–2513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gaspar NJ, Li L, Kapoun AM, Medicherla S,
Reddy M, Li G, O'Young G, Quon D, Henson M, Damm DL, et al:
Inhibition of transforming growth factor beta signaling reduces
pancreatic adenocarcinoma growth and invasiveness. Mol Pharmacol.
72:152–161. 2016. View Article : Google Scholar
|
|
43
|
Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad
A, Banerjee S, Azmi AS, Miele L and Sarkar FH: Notch-1 induces
epithelial-mesenchymal transition consistent with cancer stem cell
phenotype in pancreatic cancer cells. Cancer Lett. 307:26–36. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang Z, Banerjee S, Li Y, Rahman KM, Zhang
Y and Sarkar FH: Down-regulation of notch-1 inhibits invasion by
inactivation of nuclear factor-kappaB, vascular endothelial growth
factor, and matrix metalloproteinase-9 in pancreatic cancer cells.
Cancer Res. 66:2778–2784. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang Z, Zhang Y, Li Y, Banerjee S, Liao J
and Sarkar FH: Down-regulation of Notch-1 contributes to cell
growth inhibition and apoptosis in pancreatic cancer cells. Mol
Cancer Ther. 5:483–493. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yabuuchi S, Pai SG, Campbell NR, de Wilde
RF, De Oliveira E, Korangath P, Streppel MM, Rasheed ZA, Hidalgo M,
Maitra A, et al: Notch signaling pathway targeted therapy
suppresses tumor progression and metastatic spread in pancreatic
cancer. Cancer Lett. 335:41–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang Z, Sengupta R, Banerjee S, Li Y,
Zhang Y, Rahman KM, Aboukameel A, Mohammad R, Majumdar AP,
Abbruzzese JL, et al: Epidermal growth factor receptor-related
protein inhibits cell growth and invasion in pancreatic cancer.
Cancer Res. 66:7653–7660. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Koch U and Radtke F: Notch and cancer: A
double-edged sword. Cell Mol Life Sci. 64:2746–2762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
South AP, Cho RJ and Aster JC: The
double-edged sword of Notch signaling in cancer. Semin Cell Dev
Biol. 23:458–464. 2012. View Article : Google Scholar : PubMed/NCBI
|
